Literature DB >> 26592364

Opioids in COPD: the 'whole picture' includes results from real-world, population-based observational studies.

Nicholas T Vozoris1,2,3, Sudeep S Gill4,5, Denis E O'Donnell5.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 26592364      PMCID： PMC4799928          DOI： 10.1111/bcp.12838

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  4 in total

1.  Benefits and risks of drug treatments: how to combine the best evidence on benefits with the best data about adverse effects.

Authors:  Jan P Vandenbroucke; Bruce M Psaty
Journal:  JAMA       Date:  2008-11-26       Impact factor: 56.272

2.  Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD.

Authors:  Nicholas T Vozoris; Hadas D Fischer; Xuesong Wang; Anne L Stephenson; Andrea S Gershon; Andrea Gruneir; Peter C Austin; Geoffrey M Anderson; Chaim M Bell; Sudeep S Gill; Paula A Rochon
Journal:  Eur Respir J       Date:  2014-04-17       Impact factor: 16.671

3.  Incident opioid drug use among older adults with chronic obstructive pulmonary disease: a population-based cohort study.

Authors:  Nicholas T Vozoris; Xuesong Wang; Hadas D Fischer; Andrea S Gershon; Chaim M Bell; Sudeep S Gill; Denis E O'Donnell; Peter C Austin; Anne L Stephenson; Paula A Rochon
Journal:  Br J Clin Pharmacol       Date:  2015-10-02       Impact factor: 4.335

4.  Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study.

Authors:  Magnus P Ekström; Anna Bornefalk-Hermansson; Amy P Abernethy; David C Currow
Journal:  BMJ       Date:  2014-01-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.